Development of Acceptance Based Coping for Diabetes: A Community Health Worker-Delivered Program
* You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
In this presentation, Dr. Kathryn Kanzler discusses the prevalence and health outcome trends of type 2 diabetes in socioeconomically challenged patients. She highlights the causes of this health disparity and shares research findings about long-term effects of poorly-controlled type 2 diabetes. She also discusses the coping mechanisms that are counterproductive to good glycemic control and describes community outreach programs to help patients find acceptance in their diagnosis and improve their self-care and health outcomes.
This Endocrine Grand Rounds session took place on Friday, November 17, 2023 at 12:15 p.m. and has been approved for CME and Ethics credit.
Activity Information
How to Claim Credit
You may claim credit after watching this activity.
You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
Needs Statement
Physicians, fellows, residents, physician assistants, nurse practitioners, nurses, and other healthcare professionals need to receive regular updates on professional guidelines, advances in basic science and clinical research, and emerging treatment modalities and management strategies for patients with endocrine disorders. The series will explore new models of multidisciplinary care in the field, especially as it relates to patients with cardiometabolic diseases such as obesity and diabetes. The series aims to expand the knowledge of learners, promote adherence to evidence-based guidelines, enhance the quality of endocrinology care, disseminate best clinical practices, and improve patient outcomes.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Describe contributors to health disparities in type 2 diabetes prevalence and outcomes in Hispanic/Latinx populations.
- Identify avoidance coping techniques related to diabetes.
- List reasons for incorporating Community Health Workers in diabetes care.
- Recognize benefits of community engagement in intervention development research.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
- Endocrinology, Diabetes and Metabolism
- Family and Community Medicine
- Internal Medicine
Interest Groups
- Equity, Diversity, and Inclusion
- Ethics
- Primary Care
- Quality Improvement and Patient Safety
Activity Evaluation
Evaluation by questionnaire will address program content, presentation, and possible bias.
Educational Methods
- Lectures
- Case Presentations
- Literature Review
- Panel Discussion
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 0.75 credit of education in medical ethics and/or professional responsibility.
Activity Directors
-
Mark A. Herman, M.D.
Associate Professor of Endocrinology, Diabetes, and Metabolism; E.L. Wagner, MD Chair of Internal Medicine
Baylor College of Medicine
Term of Approval
November 1, 2023 through November 30, 2025. Original release date: November 1, 2023.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Kathryn E. Kanzler, Psy.D., A.B.P.P.
Associate Professor, Division of Health Services Research
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Activity Directors
-
Mark A. Herman, M.D.
Associate Professor of Endocrinology, Diabetes, and Metabolism; E.L. Wagner, MD Chair of Internal Medicine
Baylor College of Medicine
Disclosure:
- Research Support: Eli Lilly and Co.
Planning Committee Members
-
Layla Abushamat, M.D., M.P.H.
Instructor, Medicine − Atherosclerosis and Lipoprotein Research
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Jordana Faruqi, M.D., M.P.H.
Endocrinology Fellow
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Mark A. Herman, M.D.
Associate Professor of Endocrinology, Diabetes, and Metabolism; E.L. Wagner, MD Chair of Internal Medicine
Baylor College of Medicine
Disclosure:
- Research Support: Eli Lilly and Co.
-
Maryam Tetlay, M.D.
Endocrinology Fellow
Baylor College of Medicine
Disclosure:
Nothing to disclose.